Home Industry Reports Custom Research Blogs About Us Contact us

U.S. Iliac Stents Market

Report ID: FBI 2764

|

Published Date: May-2024

|

Format : PDF, Excel

Market Outlook

The U.S. iliac stents market is expected to witness steady growth in the coming years, driven by an increasing prevalence of peripheral artery disease (PAD) and a growing aging population. According to the Centers for Disease Control and Prevention (CDC), around 8.5 million people in the United States are affected by PAD, and this number is expected to increase as the population continues to age. Additionally, technological advancements in iliac stent design and materials are expected to drive market growth as these advancements improve the safety and efficacy of iliac stent procedures.

Iliac Stents Market

Largest Region

North America

USD 223.3 Million in 2023

Get more details on this report -

Market Dynamics

Growth Drivers:

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
1. Increasing Prevalence of Peripheral Artery Disease: The rising incidence of PAD in the U.S. population is a key driver of the iliac stents market. As the population continues to age and the prevalence of risk factors such as diabetes and obesity increases, the demand for iliac stent procedures is expected to rise.

2. Technological Advancements in Iliac Stent Design: Advancements in stent design and materials have improved the safety and efficacy of iliac stent procedures, leading to increased adoption by healthcare professionals and patients.

3. Rising Adoption of Minimally Invasive Procedures: The growing preference for minimally invasive procedures among patients and physicians is expected to drive the demand for iliac stents, as these devices are often used in endovascular procedures.

Industry Restraints:

1. Reimbursement Challenges: Reimbursement challenges and pricing pressures in the U.S. healthcare system may hinder market growth, as healthcare providers and patients may face difficulties in obtaining coverage for iliac stent procedures.

2. Complications Associated with Iliac Stent Implantation: Complications such as restenosis and thrombosis following iliac stent implantation may limit market growth, as these issues can lead to additional procedures and increased healthcare costs.

Segment Analysis

The U.S. iliac stents market can be segmented based on product type, material, and end user. Product type segments may include bare metal stents, drug-eluting stents, and covered stents, while material segments may include stainless steel, nitinol, and cobalt-chromium. End users of iliac stents may include hospitals, ambulatory surgical centers, and specialty clinics.

Competitive Landscape

Key players in the U.S. iliac stents market include major medical device companies such as Boston Scientific Corporation, Medtronic, Abbott Laboratories, and Cook Medical. These companies are investing in research and development efforts to create innovative iliac stent products and expand their market presence. Additionally, mergers and acquisitions, partnerships, and product launches are common strategies employed by these companies to maintain their competitive position in the market. Moreover, several smaller companies are also entering the market, offering specialized products and creating a competitive landscape in the U.S. iliac stents market.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Iliac Stents Market Size & Share, By Type (Self-ex...

RD Code : 24